BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 16441638)

  • 21. Ciprofloxacin resistant Neisseria gonorrhoea in New Zealand.
    Coughlan EP; Franklin RA
    N Z Med J; 1996 Mar; 109(1017):82. PubMed ID: 8606827
    [No Abstract]   [Full Text] [Related]  

  • 22. Sharp increase in ciprofloxacin resistance of
    Crucitti T; Belinga S; Fonkoua MC; Abanda M; Mbanzouen W; Sokeng E; Nzouankeu A
    Int J STD AIDS; 2020 May; 31(6):579-586. PubMed ID: 32316853
    [No Abstract]   [Full Text] [Related]  

  • 23. Suboptimal therapy and clinical management of gonorrhoea in an area with high-level antimicrobial resistance.
    Chen PL; Hsieh YH; Lee HC; Ko NY; Lee NY; Wu CJ; Chang CM; Lee CC; Ko WC
    Int J STD AIDS; 2009 Apr; 20(4):225-8. PubMed ID: 19304963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gonorrhoea: test of cure for sensitive bacteria? Use of genotyping to disprove treatment failure.
    Komolafe AJ; Sugunendran H; Corkill JE
    Int J STD AIDS; 2004 Mar; 15(3):212. PubMed ID: 15038877
    [No Abstract]   [Full Text] [Related]  

  • 25. The rise and fall of ciprofloxacin-resistant Neisseria gonorrhoeae in Liverpool.
    Corkill JE; Kelly C; Neal T; Alawattegama AB; Hart CA
    Int J STD AIDS; 2005 Jan; 16(1):83. PubMed ID: 15705281
    [No Abstract]   [Full Text] [Related]  

  • 26. High prevalence of high-level ciprofloxacin resistance in Neisseria gonorrhoeae in Tel Aviv, Israel: correlation with response to therapy.
    Dan M; Poch F; Sheinberg B
    Antimicrob Agents Chemother; 2002 Jun; 46(6):1671-3. PubMed ID: 12019074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multidrug-resistant Neisseria gonorrhoeae with decreased susceptibility to cefixime-Hawaii, 2001.
    Wang SA; Lee MV; O'Connor N; Iverson CJ; Ohye RG; Whiticar PM; Hale JA; Trees DL; Knapp JS; Effler PV; Weinstock HS
    Clin Infect Dis; 2003 Sep; 37(6):849-52. PubMed ID: 12955650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surveillance of antimicrobial susceptibilities in Neisseria gonorrhoeae in Nanjing, China, 1999-2006.
    Su X; Jiang F; Qimuge ; Dai X; Sun H; Ye S
    Sex Transm Dis; 2007 Dec; 34(12):995-9. PubMed ID: 17595594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emergence of quinolone-resistant Neisseria gonorrhoeae in Pakistan.
    Jabeen K; Khan E; Hasan R
    Int J STD AIDS; 2006 Jan; 17(1):30-3. PubMed ID: 16409676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High incidence of treatment failure of Neisseria gonorrhoeae isolates to ciprofloxacin in male gonococcal urethritis in Delhi.
    Chowdhry S; Pandhi D; Vidhani S; Bhalla P; Reddy BS
    Int J STD AIDS; 2002 Aug; 13(8):564-7. PubMed ID: 12194741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment failure with the use of ciprofloxacin for gonorrhea correlates with the prevalence of fluoroquinolone-resistant Neisseria gonorrhoeae strains in Bangladesh.
    Rahman M; Alam A; Nessa K; Nahar S; Dutta DK; Yasmin L; Monira S; Sultan Z; Khan SA; Albert MJ
    Clin Infect Dis; 2001 Mar; 32(6):884-9. PubMed ID: 11247712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. First case of spectinomycin resistant Neisseria gonorrhoeae isolate in New Delhi, India.
    Bala M; Ray K; Salhan S
    Sex Transm Infect; 2005 Apr; 81(2):186-7. PubMed ID: 15800110
    [No Abstract]   [Full Text] [Related]  

  • 33. Changing epidemiologic profile of quinolone-resistant Neisseria gonorrhoeae in London.
    Martin IM; Ison CA; Aanensen DM; Fenton KA; Spratt BG
    J Infect Dis; 2005 Oct; 192(7):1191-5. PubMed ID: 16136461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increasing resistance to ciprofloxacin among isolates of Neisseria gonorrhoea in Dublin.
    Hopkins S; Coleman C; Kelleher M; Keating S; Clarke S; O'Connell B; Mulcahy F; Bergin C
    Ir Med J; 2005; 98(7):208-9. PubMed ID: 16185017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors related to increasing prevalence of resistance to ciprofloxacin and other antimicrobial drugs in Neisseria gonorrhoeae, United States.
    Goldstein E; Kirkcaldy RD; Reshef D; Berman S; Weinstock H; Sabeti P; Del Rio C; Hall G; Hook EW; Lipsitch M
    Emerg Infect Dis; 2012 Aug; 18(8):1290-7. PubMed ID: 22840274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Escalation in the relative prevalence of ciprofloxacin-resistant gonorrhoea among men with urethral discharge in two South African cities: association with HIV seropositivity.
    Lewis DA; Scott L; Slabbert M; Mhlongo S; van Zijl A; Sello M; du Plessis N; Radebe F; Wasserman E
    Sex Transm Infect; 2008 Oct; 84(5):352-5. PubMed ID: 18596070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Increasing incidence of ciprofloxacin resistant gonorrhea in Sweden. Choose a correct antibiotic and follow up the treatment!].
    Berglund T; Colucci B; Lund B; Qvarnström I; Sandström E
    Lakartidningen; 2004 Jul; 101(28-29):2332-5. PubMed ID: 15291311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimicrobial susceptibility profile of
    Affolabi D; Goma E; Sogbo F; Ahotin G; Orekan J; Massou F; Behanzin L; Guédou F; Alary M
    Sex Transm Infect; 2018 Feb; 94(1):20. PubMed ID: 29021407
    [No Abstract]   [Full Text] [Related]  

  • 39. High prevalence of ciprofloxacin resistance amongst strains of Neisseria gonorrhoeae isolated from commercial sex workers in Bangladesh.
    Bhuiyan BU; Miah RA; Rahman M; Rahman KM; Albert MJ
    J Antimicrob Chemother; 1998 Nov; 42(5):675-6. PubMed ID: 9848459
    [No Abstract]   [Full Text] [Related]  

  • 40. Low prevalence of ciprofloxacin-resistant Neisseria gonorrhoeae in Nuuk, Greenland.
    Pedersen ML; Clausen-Dichow P; Poulsen P; Nyborg H; Jensen JS
    Sex Transm Dis; 2013 Aug; 40(8):639-40. PubMed ID: 23859910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.